1KASTRINAKI MC, PAPADAKI HA. Mesenchymal stromal cells in rheumatoid arthritis biological properties and clinical applications[J]. Curr Srom Cell Res Ther, 2009, 4(1): 61-69.
2VAN DER HE[JDE D M, VAN'T HOF M, VAN RIEL PL, et al. Development of a disease activity score based on judgment in clinical practice by rheumatologists [J]. J Rheumatol, 1993,20(3): 579-581.
3DOMER T, BURMESTER G R. The role of B ceils in rheum- atoid arthritis: mechanisms and therapeutic trgets[J]. Curt Opin Rheumatol, 2003,15(3):246-251.
4KIM W U, KIM K J. T cell proliferate response to type II collagen in the inflammatory process and joint damage in patients with rheumatoid arthritis[J]. J Rheumatol,2005,32 (3):225-230.
5LUBBERTS E, SCHWARZENBERGER P, HUANG Wet al. Requirement of L-17 receptor signaling in radiation resistant cells in the joint for full progression of destructive synovitis [J]. J hnmunol,2005,175(5):3360-3368.
7KASTRINAKI M C, PAPADAKI H A. Mesenchamal stro- mal cells in rheumatoid arthritis: biological proterties andclinical appliacations[J]. Curt Stem Cell Res Ther,2009,4 (1):61-69.
8KALWITZ G, ENDRES M, NEUMANN K, et al. Gene ex- pression profile of adult human bone marrow-derived mesenchymal stem cells stimulated by the chemokine CXCL7[J]. Int Biochem Cell Biol,2009,41 (3):649-658.
9GAO J, DEMNIS J E, SOLCHANA L Aet al. Tissue engi- neered fabrication of an osteochondral composite graft using rat bone marrow derived mesenchymal stem cells[J]. Tis- sue Eng,2001,7(4):363-371.
10FRANGOGIANNIS N G. The immune system and cardiac repair[J]. Pharmacol Res, 2008,58(2): 88-111.
